Chris Easton

Chris Easton is a distinguished pharma leader with a rich 21-year career spanning various levels within the industry, including local, regional, and global roles. Chris is deeply committed to transforming the traditional pharma paradigm from 'SICKcare' to 'HEALTHcare' and excels in driving brand growth, consistently surpassing targets.

His expertise lies in strategic launch planning for novel biologics across different therapeutic areas, both nationally and internationally. With a focus on operational and financial enhancements, Chris has a track record of success in the pharmaceutical, biotechnology, and medical device sectors.

Known for his exceptional leadership skills, Chris has a knack for fostering high-performing teams and promoting cross-functional collaboration to drive business initiatives, streamline workflows, and reduce operational expenses. His core motivators include innovative thinking, a can-do attitude, team cohesion, and organizational adaptability.

Chris's educational background includes studies in Market Access at INSEAD, an Executive Leadership Program at Henley Business School, and a 2:1 (Hons) degree in Business, Management, Marketing, and Related Support Services from Solent University.

In his professional journey, Chris has held key positions such as Senior Director of Global Commercial Lead at Takeda, focusing on Personalized Health & Innovation, and Rare Hematology. He has also served as the Senior Director of Global Commercial Lead for Portfolio Strategy & Market Development at Takeda, and has contributed his expertise as Marketing & Commercial Consultant/International Brand Director at TESARO, Inc.

Furthermore, Chris has held significant roles at Novo Nordisk, including Biopharm Director, Business Unit Head for Commercial Excellence in Europe, as well as various Global Marketing positions. His experience also extends to Baxter International Inc., where he served as the EMEA Marketing Manager and Senior Product Manager in the Advanced Chronic Care (ACC) division.